Abstract
PURPOSE
There is strong evidence that leisure-time physical activity is protective against postmenopausal breast cancer risk but the association with premenopausal breast cancer is less clear. The purpose of this study was to examine the association of physical activity with the risk of developing premenopausal breast cancer.
METHODS
We pooled individual-level data on self-reported leisure-time physical activity across 19 cohort studies comprising 547,601 premenopausal women, with 10,231 incident cases of breast cancer. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% CIs for associations of leisure-time physical activity with breast cancer incidence. HRs for high versus low levels of activity were based on a comparison of risk at the 90th versus 10th percentiles of activity. We assessed the linearity of the relationship and examined subtype-specific associations and effect modification across strata of breast cancer risk factors, including adiposity.
RESULTS
Over a median 11.5 years of follow-up (IQR, 8.0-16.1 years), high versus low levels of leisure-time physical activity were associated with a 6% (HR, 0.94 [95% CI, 0.89 to 0.99]) and a 10% (HR, 0.90 [95% CI, 0.85 to 0.95]) reduction in breast cancer risk, before and after adjustment for BMI, respectively. Tests of nonlinearity suggested an approximately linear relationship (Pnonlinearity = .94). The inverse association was particularly strong for human epidermal growth factor receptor 2–enriched breast cancer (HR, 0.57 [95% CI, 0.39 to 0.84]; Phet = .07). Associations did not vary significantly across strata of breast cancer risk factors, including subgroups of adiposity.
CONCLUSION
This large, pooled analysis of cohort studies adds to evidence that engagement in higher levels of leisure-time physical activity may lead to reduced premenopausal breast cancer risk.
INTRODUCTION
Physical activity is an important modifiable behavior, with higher levels of activity strongly associated with reduced risk of all-cause mortality,1 cardiovascular disease,2 and some cancer types.3 Although previous studies have established an inverse association of leisure-time physical activity with postmenopausal breast cancer risk, it is unclear whether the same is true for premenopausal breast cancer, which represents the leading cancer diagnosis among reproductive-age women worldwide.4,5
CONTEXT
Key Objective
Despite the strong evidence of a beneficial effect of physical activity on some cancer types, including postmenopausal breast cancer, less is known about the role of physical activity in reducing premenopausal breast cancer risk. This study sought to investigate this subject in a large international, pooled cohort study.
Knowledge Generated
Risk of premenopausal breast cancer was reduced in those with higher levels of leisure-time physical activity, and this inverse association strengthened after adjustment for BMI. The association was approximately linear in its dose-response relationship, with a stronger subtype-specific effect on human epidermal growth factor receptor 2–positive breast cancer.
Relevance (I. Cheng)
-
Leisure-time physical activity may serve as a possible modifiable risk factor for premenopausal breast cancer that may be targeted for the prevention of this disease.*
*Relevance section written by JCO Associate Editor Iona Cheng, PhD, MPH.
Previous prospective cohort studies have reported inconclusive findings on the association between physical activity and premenopausal breast cancer risk,6-16 due in part to the low numbers of breast cancer cases during follow-up, and hence, low statistical power. By contrast, meta-analyses17-22 have been better powered but limited by high levels of heterogeneity across studies, likely because of differences in questionnaire designs, types of physical activity measured (eg, leisure-time, occupational), and modeling assumptions regarding important potential confounders and mediators such as BMI. Moreover, previous studies have examined potential effect modifiers of the physical activity-breast cancer association, including age, BMI, family history of breast cancer, race and ethnicity, and parity; however, among premenopausal women, the evidence for any such factors is limited and inconsistent.18,19,23,24 There is, however, stronger evidence that no association exists among premenopausal women with higher BMI.19 Additionally, investigation of subtype-specific associations is lacking and may provide greater insight into potential mechanisms.
To address the limitations of previous studies, we assessed the association between self-reported leisure-time physical activity and premenopausal breast cancer risk in a pooled analysis of 19 prospective cohort studies of 547,601 women, with 10,231 incident cases of breast cancer. We used data from studies that measured leisure-time physical activity, harmonized across studies to cohort-specific percentiles, and estimated the relative risk across a large contrast of the highest activity levels (90th percentile) versus the lowest levels (10th percentile). Leisure-time activity was of particular interest as it is potentially modifiable and targetable through cancer prevention efforts. Using individual-level participant data, we assessed the linearity of the relationships between activity levels and cancer risk, the associations within breast cancer subtypes, and the evidence of effect modification by strata of breast cancer risk factors.
METHODS
Data
We used data from 19 of the 22 cohort studies in the Premenopausal Breast Cancer Collaborative Group25 that had available data on participants’ self-reported leisure-time physical activity data. Individual-level data were pooled across studies from North America (n = 10), Europe (n = 6), Asia (n = 2), and Australia (n = 1).
This secondary analysis was approved by the relevant institutional review boards, and women provided informed consent to participate in the original studies. Full details of the study cohorts are provided in the Data Supplement (Table S1, online only).
Leisure-Time Physical Activity Assessment
Leisure-time physical activities are defined as those performed at an individual's discretion and are not required as essential activities of daily living; examples include sports, exercise, and recreational walking. Within each study, metabolic equivalents of task (METs, the ratio of the energy cost of an activity to the energy expenditure at rest) were derived from questionnaire information and used to quantify physical activity.
Each cohort assessed physical activity either by recording information on overall weekly participation in moderate- and vigorous-intensity activities, or on discrete activities such as walking, running, and cycling. Current guidelines define moderate activity as three to six METs, and vigorous activity as six or more METs.26 The intensity of discrete activities was converted to METs as per the 2011 Compendium.27
Seventeen of the 19 cohorts assessed time per week participating in moderate and vigorous leisure-time physical activities, enabling calculation of total leisure-time MET-hours per week. One cohort included only vigorous-intensity activity,28 and one cohort evaluated frequency of moderate-to vigorous-intensity activities, but not time spent.29 Validation studies for the exposures of each study are described in the Data Supplement (Table S2).
Following the approach of Moore et al,30 leisure-time physical activity MET levels were harmonized by converting them to cohort-specific percentiles, ranging from 0 (relatively low activity) to 100 (relatively high activity).
Outcomes
The main end point was diagnosis with a first invasive or in situ premenopausal breast cancer after exposure assessment. We also conducted analyses of invasive and in situ outcomes separately, as well as by estrogen receptor (ER) and progesterone receptor status (PR), and by clinicopathologic surrogate definitions of intrinsic breast cancer subtype.31
Follow-up for breast cancer began with the baseline (enrollment) questionnaire, or at the first questionnaire for which leisure-time physical activity data were recorded. As in previous reports from this collaboration,32,33 observation time continued until breast cancer diagnosis, with censoring at menopause, last follow-up, death, or age 55 years, whichever occurred first.
Statistical Analysis
We used Cox proportional hazards models to calculate hazard ratios (HRs) and 95% CIs for the association between quintiles of leisure-time physical activity and breast cancer, with attained age as the underlying time scale.
In addition, HRs comparing the 90th and 10th percentiles of cohort-specific distributions were computed as e90β–10β, where β is the log HR from the linear model for the continuous physical activity percentile.30
We first generated cohort-specific HRs and then obtained a pooled estimate across studies using a random-effects meta-analysis, with weights assigned on the basis of the inverse of the study-specific variance. Because we observed minimal heterogeneity between cohorts with the Cochran Q test and I2 statistic,34 we pooled individual-level data across cohorts for all subsequent analyses.
As in previous analyses,33,35 to include the case-cohort study (Canadian Study of Diet, Lifestyle, and Health) in the pooled analysis, we included Barlow weights36 corresponding to a sampling fraction of 5.0% as an offset in the model.
Models were adjusted for cohort, year of birth, age at menarche (<12, 12-13, ≥14 years, missing), parity (0, 1, 2, ≥3 births, missing), oral contraceptive use (ever, never, missing), first-degree family history of breast cancer (yes, no/missing), smoking status (ever, never, missing), and race and ethnicity (White, Black, Asian, Hispanic, other/missing). We performed further analyses adjusting for alcohol consumption, excluding 10 cohorts where these data were unavailable. Covariate information was updated over follow-up, where available.
We investigated the impact of BMI, time updated where information was available, on findings by presenting results from all models with and without adjustment for BMI (<18.5, 18.5-25, 25-30, 30-35, >35 kg/m2).
We assessed effect modification by attained age (25-34, 35-44, ≥45 years), BMI, age at menarche, parity, oral contraceptive use, first-degree family history of breast cancer, smoking status, birth cohort, and race and ethnicity. P values for each interaction were obtained using log-likelihood ratio tests, which were declared significant if P < .05.
To further assess the relationship between leisure-time physical activity and premenopausal breast cancer risk, we examined HRs across quintiles of leisure-time physical activity. Additionally, we tested for evidence of nonlinearity by applying a likelihood ratio test to three-knot restricted cubic spline models with knots at the 10th, 50th, and 90th percentiles of leisure-time physical activity.
For subtype-specific analyses, we censored at breast cancer events that were not the subtype of interest. Additionally, we used a data augmentation method37 with the Wald test38 to test for heterogeneity (denoted Phet) in the associations with leisure-time physical activity across breast cancer subtypes.
All statistical analyses were conducted using STATA 16.0 (College Station, TX).
Ethics Approval and Informed Consent
Individual study protocols were approved by the relevant institutional review boards and obtained informed consent from participants.
RESULTS
Our pooled data set contained information from 547,601 women, whose median age at exposure assessment was 41.3 years (IQR, 35.2-45.8 years). During the 5,113,522 years of follow-up time (median, 11.5 years; IQR, 8.0-16.1 years), 10,231 in situ or invasive breast cancer cases were diagnosed. Descriptive characteristics for the women included in the analysis are shown in Table 1. Distributions of age and breast cancer risk factors such as BMI were broadly similar across cohorts; however, likely reflecting the varying questionnaire designs, the distribution of leisure-time physical activity showed substantial variation (Data Supplement, Table S1). In view of this, we performed pooled analyses using cohort-specific percentiles and quintiles of physical activity.
TABLE 1.
Characteristics at Study Entry of Women Included in Analyses, by Quintiles of Leisure-Time Physical Activity
| Characteristic | Participants (N = 547,601), No. | Person-Years of Follow-Up | Quintile of Leisure-Time Physical Activity | Breast Cancer Cases (n = 10,231), No. | ||||
|---|---|---|---|---|---|---|---|---|
| Q1 (least active; n = 109,528), % | Q2 (n = 109,525), % | Q3 (n = 109,521), % | Q4 (n = 109,515), % | Q5 (most active; n = 109,512), % | ||||
| BMI (at entry), kg/m2 | ||||||||
| <18.5 | 14,327 | 154,961 | 3 | 3 | 2 | 2 | 3 | 323 |
| 18.5-24.9 | 342,377 | 3,296,922 | 57 | 60 | 63 | 65 | 67 | 6,977 |
| 25-29.9 | 123,683 | 1,070,977 | 23 | 23 | 23 | 22 | 21 | 1,972 |
| 30-34.9 | 43,426 | 376,692 | 10 | 9 | 8 | 7 | 6 | 657 |
| ≥35 | 23,788 | 213,970 | 7 | 5 | 4 | 3 | 3 | 302 |
| Age at entry, years | ||||||||
| <25 | 15,847 | 201,027 | 3 | 3 | 3 | 3 | 4 | 75 |
| 25-34 | 119,817 | 1,907,318 | 21 | 22 | 22 | 22 | 23 | 2,497 |
| 35-44 | 255,193 | 2,453,678 | 47 | 46 | 47 | 48 | 45 | 5,702 |
| ≥45 | 156,744 | 551,499 | 30 | 30 | 29 | 27 | 28 | 1,957 |
| Age at menarche, years | ||||||||
| 7-11 | 114,826 | 1,106,948 | 22 | 21 | 21 | 21 | 21 | 2,273 |
| 12-13 | 292,018 | 2,785,266 | 53 | 54 | 53 | 54 | 53 | 5,614 |
| ≥14 | 128,555 | 1,129,639 | 23 | 23 | 24 | 23 | 25 | 2,148 |
| Missing or no periods | 12,202 | 91,669 | 2 | 2 | 2 | 2 | 2 | 196 |
| Parity | ||||||||
| 0 | 102,331 | 805,357 | 16 | 17 | 18 | 20 | 22 | 1,404 |
| 1 | 102,506 | 855,620 | 20 | 20 | 19 | 18 | 17 | 1,668 |
| 2 | 182,461 | 1,791,735 | 33 | 34 | 34 | 34 | 31 | 3,909 |
| ≥3 | 115,097 | 1,065,575 | 21 | 21 | 21 | 21 | 22 | 2,242 |
| Not known | 45,206 | 595,736 | 10 | 8 | 8 | 7 | 8 | 1,008 |
| Family history of breast cancer | ||||||||
| Yes | 63,380 | 645,068 | 12 | 12 | 11 | 12 | 11 | 2,328 |
| No | 357,285 | 3,511,005 | 64 | 64 | 65 | 67 | 68 | 6,132 |
| Not known | 126,936 | 957,449 | 25 | 25 | 24 | 22 | 21 | 1,771 |
| Oral contraceptive use | ||||||||
| Ever | 418,147 | 3,888,483 | 76 | 77 | 77 | 76 | 75 | 7,362 |
| Never | 103,696 | 1,054,549 | 19 | 18 | 18 | 19 | 20 | 2,449 |
| Not known | 25,758 | 170,490 | 5 | 5 | 5 | 5 | 5 | 420 |
| Smoking status | ||||||||
| Never | 207,345 | 1,816,693 | 39 | 38 | 37 | 38 | 38 | 4,003 |
| Former/current | 323,624 | 3,206,299 | 58 | 59 | 60 | 59 | 59 | 5,995 |
| Not known | 16,632 | 90,530 | 3 | 3 | 3 | 3 | 3 | 233 |
| Race/ethnicity | ||||||||
| Black | 43,355 | 477,088 | 8 | 8 | 8 | 8 | 8 | 811 |
| Asian | 14,287 | 107,251 | 3 | 3 | 2 | 2 | 2 | 185 |
| White | 325,452 | 3,219,638 | 58 | 59 | 60 | 60 | 60 | 6,632 |
| Hispanic | 11,400 | 125,370 | 2 | 2 | 2 | 2 | 2 | 242 |
| Other/not known | 153,107 | 1,184,174 | 28 | 28 | 28 | 28 | 28 | 2,361 |
| Birth cohort | ||||||||
| Before 1940 | 30,723 | 97,863 | 6 | 6 | 6 | 5 | 6 | 400 |
| 1940-1949 | 156,147 | 971,137 | 29 | 29 | 28 | 29 | 28 | 2,864 |
| 1950-1959 | 214,595 | 2,209,444 | 39 | 39 | 40 | 40 | 39 | 4,386 |
| 1960-1969 | 105,535 | 1,408,527 | 19 | 19 | 19 | 19 | 20 | 2,299 |
| 1970-1979 | 32,683 | 360,908 | 6 | 6 | 6 | 6 | 6 | 260 |
| 1980 or later | 7,918 | 65,643 | 1 | 1 | 1 | 2 | 2 | 22 |
Leisure-time physical activity was inversely associated with BMI at exposure assessment (P < .001), where mean BMI was 25.3 kg/m2 (standard deviation [SD], 5.5 kg/m2), 24.5 kg/m2 (SD, 4.7 kg/m2), and 23.9 kg/m2 (SD, 4.3 kg/m2) across the first (least active), third, and fifth (most active) quintiles of leisure-time physical activity, respectively. Lower levels of leisure-time physical activity were also associated with having a first-degree family history of breast cancer and ever smoking (Data Supplement, Table S3).
On the basis of a linear trend model for physical activity in the pooled data, a higher level of leisure-time physical activity (90th percentile) compared with a lower level of activity (10th percentile) was associated with a 6% (HR, 0.94 [95% CI, 0.89 to 0.99]; P = .02) reduced breast cancer risk (Fig 1). Further adjusting for BMI as a covariate increased the strength slightly (HR, 0.90 [95% CI, 0.85 to 0.95]; P < .001). Random-effects meta-analysis provided no evidence of significant heterogeneity in the association between studies (I2 = 0.0%; Q value = 12.4; P = .83; Data Supplement, Tables S4 and S5). Cohort-specific associations are presented in the Data Supplement (Fig S1). A leave-one-out analysis provided no evidence that associations were overly influenced by a single contributing cohort (Data Supplement, Table S6).
FIG 1.

HRs for breast cancer in relation to leisure-time physical activity from the analysis (A) without and (B) with adjustment for BMI, respectively. HRs are with reference to the 10th percentile of leisure-time physical activity. Shaded areas represent 95% CIs. Three knots are positioned at the 10th, 50th, and 90th percentiles of leisure-time physical activity. HR, hazard ratio.
When leisure-time physical activity was modeled as a categorical variable (ie, defined using cohort-specific quintiles), we observed a graded decrease in breast cancer risk with increasing levels of physical activity (Table 2). Using cubic splines, we observed no evidence that the association between leisure-time physical activity and breast cancer was nonlinear (Pnonlinearity = .94), and HR estimates from the cubic splines approximately paralleled those from the categorical analysis on the basis of quintiles (Fig 1).
TABLE 2.
HRs for Invasive and In Situ Breast Cancer in Relation to Quintiles of Leisure-Time Physical Activity, in a Pooled Analysis of 19 Cohorts
| Variable | Quintile of Leisure-Time Physical Activity | P for Linear Trend | ||||
|---|---|---|---|---|---|---|
| 1 (least active) | 2 | 3 | 4 | 5 (most active) | ||
| Participants, No. | 109,528 | 109,525 | 109,521 | 109,515 | 109,512 | |
| Breast cancer cases, No. | 2,103 | 2,078 | 2,056 | 2,001 | 1,993 | |
| Person-years | 1,004,328 | 1,011,280 | 1,017,657 | 1,035,960 | 1,044,297 | |
| HR (95% CI) | ||||||
| Fully adjusteda | 1.00 (ref) | 0.98 (0.92 to 1.04) | 0.97 (0.91 to 1.03) | 0.94 (0.88 to 0.99) | 0.94 (0.88 to 1.00) | .02 |
| Further adjusted for BMI | 1.00 (ref) | 0.97 (0.92 to 1.03) | 0.95 (0.90 to 1.01) | 0.92 (0.86 to 0.97) | 0.91 (0.85 to 0.97) | <.001 |
Abbreviations: HR, hazard ratio; ref, reference.
Adjusted for cohort, year of birth, age at menarche, parity, age at first birth, oral contraceptive use, family history of breast cancer, smoking status, and race/ethnicity.
A sensitivity analysis was performed that included further adjustment for alcohol consumption, using a reduced set of 222,950 women across nine cohorts. Within this set of cohorts, we observed that higher (90th percentile) compared with lower (10th percentile) levels of leisure-time physical activity were associated with a 7% (HR, 0.93 [95% CI, 0.84 to 1.02]) and an 8% (HR, 0.92 [95% CI, 0.83 to 1.02]) reduced risk of breast cancer, respectively, for results unadjusted and adjusted for alcohol consumption (Data Supplement, Table S7).
We found no evidence of reverse causation since there was a relatively minor difference in the estimated HR when we excluded person-time occurring within the first 2 years of follow-up. After these exclusions, the estimated risk reductions were 5% (HR, 0.95 [95% CI, 0.90 to 1.01]) and 10% (0.90 [95% CI, 0.85 to 0.96]) before and after adjustment for BMI, respectively (Data Supplement, Table S8).
We performed further analyses assessing whether leisure-time physical activity might differentially affect breast cancer subtypes (Fig 2; Data Supplement, Table S9). Incident cases included 8,165 invasive and 1,971 in situ breast cancers, and the strength of association with leisure-time physical activity was consistent (Phet = .89) for both invasive (HR, 0.94 [95% CI, 0.89 to 1.00]) and in situ (HR, 0.95 [95% CI, 0.84 to 1.07]) breast cancer. ER status was known for 6,964 cases within 16 cohorts, and we observed a slightly stronger magnitude of association for ER-positive (HR, 0.94 [95% CI, 0.87 to 1.01]) compared with ER-negative (HR, 0.98 [95% CI, 0.86 to 1.13]) breast cancer (Phet = .52). We performed further analyses by intrinsic subtype, which were defined in 4,135 cases across 12 of the 19 cohorts. We found some evidence (Phet = .07) of differences in effect size across luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)–enriched, and triple-negative breast cancers. Notably, within the nonluminal subtypes (ER-negative and PR-negative), associations differed markedly by HER2 status. We observed a much larger effect size estimate for HER2-enriched breast cancer, where higher (90th percentile) compared with lower (10th percentile) levels of activity were associated with an estimated 43% reduction in HER2-enriched breast cancer risk (HR, 0.57 [95% CI, 0.39 to 0.84]; P < .001). The association with HER2-enriched breast cancer remained similar in magnitude after adjustment for BMI. By contrast, there was no association with triple-negative breast cancer (HR, 1.08 [95% CI, 0.83 to 1.40]; P = .58), which was little changed by adjustment for BMI.
FIG 2.

HRs for breast cancer for a higher (90th percentile) versus lower (10th percentile) level of leisure-time physical activity, by breast cancer subtype. aAdjusted for attained age (implicit time scale in Cox regression model), cohort, year of birth, age at menarche, parity, oral contraceptive use, first-degree family history of breast cancer, smoking status, and race/ethnicity. bAdjusted for covariates in the footnote a plus BMI. ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; HR, hazard ratio; PR, progesterone receptor.
In stratified analyses, we found no clear pattern in the strength of association between leisure-time physical activity and breast cancer risk across strata of BMI (Pinteraction = .33), although we did observe both a significant reduction in risk of 32% (HR, 0.68 [95% CI, 0.51 to 0.92]; P = .01) and 9% (HR, 0.91 [95% CI, 0.85 to 0.87]; P = .005) for underweight (<18.5 kg/m2) and normal-weight (18.5-24.9 kg/m2) women, respectively. Additionally, within strata of race and ethnicity, we found some evidence of a stronger reduction in risk for Hispanic women (HR, 0.75 [95% CI, 0.58 to 1.01]; P = .06) and White women (HR, 0.94 [95% CI, 0.88 to 1.00]; P = .05), compared with a null association for Black women (HR, 1.06 [95% CI, 0.87 to 1.28]; P = .56). There was no evidence of interaction effects for other breast cancer risk factors, including smoking status and family history of breast cancer (Fig 3; Data Supplement, Table S10).
FIG 3.

HRs for breast cancer for a higher (90th percentile) versus lower (10th percentile) level of leisure-time physical activity, by selected subgroups. aAdjusted for attained age (implicit time scale in Cox regression model), cohort, year of birth, age at menarche, parity, oral contraceptive use, first-degree family history of breast cancer, smoking status, and race/ethnicity. bAdjusted for covariates in the footnote a plus BMI. HR, hazard ratio.
DISCUSSION
In this pooled analysis of over 540,000 women from 19 prospective cohort studies, we found an inverse association between leisure-time physical activity and premenopausal breast cancer risk. We estimated a reduction in risk of 6%, which further strengthened to 10% after adjustment for BMI. This association was robust to adjustment for a range of breast cancer risk factors and lifestyle behaviors, suggesting minimal influence of residual confounding.
Our findings are broadly consistent with two recent meta-analyses that have assessed the association between leisure-time physical activity and premenopausal breast cancer risk. A report from the Continuous Update Project22 included 12 cohort studies, of which four cohorts contributed to our pooled analysis, in a meta-analysis of around 4,000 cases, and estimated a 7% reduction in risk of premenopausal breast cancer when comparing high versus low levels of leisure-time physical activity. Another study by Neilson et al19 included separately both 13 cohort studies and 36 case-control studies and estimated a stronger risk reduction of 20% when comparing high versus low levels of leisure-time activity, which attenuated slightly to 17% when restricted only to cohort studies. By contrast, results from individual cohort studies have been inconsistent in both the strength and significance of reported associations, likely owing to low power, given the small numbers of cases in each. It was notable that only one study (Nurses' Health Study I) within our analysis of 19 studies displayed an individually significant finding at P < .05 (unadjusted for BMI), demonstrating the gains in power in our pooled study.
We also examined the interaction between physical activity and BMI in relation to breast cancer risk. Previous studies have provided some evidence of BMI as an effect modifier, with a review by Neilson et al19 on the basis of seven cohort studies of premenopausal women finding no association among overweight and obese women (relative risk, 0.99), while observing a 15% reduced risk among normal-weight and underweight women. Our results appeared broadly consistent with this, as we observed a strong reduction in risk of 32% associated with physical activity in underweight women along with a significant reduction in risk of 9% in normal-weight women, with weaker evidence in overweight and obese women. A combined role of physical activity, BMI, and energy balance may in part explain the stronger association observed among underweight women.7,39 For instance, higher physical activity levels, particularly when combined with inadequate energy intake,40 could affect menstrual function,41,42 increase likelihood of anovulatory cycles,43 and reduce hormonal exposures that influence breast cancer risk.
We found that the association with risk of breast cancer remained regardless of whether leisure-time physical activity was modeled in terms of continuous percentiles, or categories on the basis of quintiles, which suggested a graded decrease in risk with increasing activity. Moreover, a spline analysis suggested an approximately linear inverse relationship between increasing activity levels and breast cancer risk. This could explain why previous individual cohort studies22,44 and a recent Mendelian randomization analysis have consistently observed the strongest risk reductions at high levels of moderate- to vigorous-intensity activity.
In further analyses by subtype, we found no statistical evidence of effect heterogeneity by tumor invasiveness or combinations of ER and PR status; however, given the potentially limited statistical power, it was unclear whether this finding suggested that a protective effect of physical activity generalizes across most breast tumors. Notably, we observed a stronger inverse association with HER2-enriched breast cancer, which displayed a 43% reduction in risk, and this could lend further support to the role of estrogen-independent pathways in premenopausal women, as suggested previously.19 Further work is required to validate these findings and clarify potential subtype-specific associations.
There is substantial evidence for multiple mechanisms,45 and although exact mechanisms are currently unclear, several pathways linking physical activity to premenopausal breast cancer risk have been proposed.46,47 Some evidence suggests that physical activity causes reduced levels of sex steroid hormones such as estrogens and androgens,48-50 which could mediate an effect on breast cancer risk. Additionally, the impact of physical activity on decreasing fasting insulin levels and insulin/insulin-like growth factor signaling could also drive breast cancer risk,51 including through a direct effect on tumor growth.52 Higher insulin levels may also reduce sex hormone–binding globulin levels and thereby increase bioavailability of estrogens and androgens,53 suggesting another possible mechanism. The anti-inflammatory effects of physical activity may also play a role.54
The strengths of our study include the prospective nature of contributing studies, the large number of cases, and the inclusion of many studies across multiple countries, which reduces the influence of study-specific effects and improves the robustness of findings. Additionally, the detailed covariate information and multiple follow-up rounds for several contributing studies enabled inclusion of time-updated covariates. The pooled cohort design also avoids many of the limitations present in existing meta-analyses, such as methodologic differences across contributing studies and potential publication bias.
There are several limitations to note. First, there was substantial heterogeneity in the distribution of leisure-time MET-hours/week across cohorts, which is likely to be primarily attributable to varying questionnaire designs. Although we sought to address this issue by ranking participants' activity levels within each study, we were unable to use absolute METs as a metric for analysis or draw conclusions about recommended levels of physical activity. Second, we restricted our analysis to a single, harmonized measure of leisure-time physical activity, and we were unable to further assess associations with type, amount, frequency, and intensity of activities, as well as occupational and total activity, because of limited and inconsistent reporting of these measures across studies. Third, we were limited by our reliance on self-reported physical activity measures. Although questionnaire-based measures of physical activity have been reported to be valid, particularly when ranking activity levels, misclassification can still result from factors such as social desirability bias. Finally, the findings may be subject to unmeasured and residual confounding.
In summary, this international study of over 540,000 women suggested a small protective effect of leisure-time physical activity on premenopausal breast cancer risk, providing evidence to support breast cancer prevention efforts. Our findings also supported a linear dose-response relationship for this association, while a potentially stronger relationship with HER2-enriched breast cancer could indicate subtype-specific effects.
ACKNOWLEDGMENT
The authors thank the National Cancer Institute Cohort Consortium for facilitating this collaboration. The Black Women's Health Study obtained pathology data on breast cancer from state cancer registries in AZ, CA, CO, CT, DE, DC, FL, GA, IL, IN, KY, LA, MD, MA, MI, NJ, NY, NC, OK, PA, SC, TN, TX, and VA. The authors acknowledge the Netherlands Cancer Registry (NKR) and Statistics Netherlands.
Iain R. Timmins
Employment: AstraZeneca
Corinne E. Joshu
Honoraria: National Cancer Institute, American Cancer Society
Research Funding: National Cancer Institute (Inst), American Cancer Society (Inst), Ralph Lauren Corporate Foundation (Inst), National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) (Inst)
Lene Mellemkjaer
Employment: Novo Nordisk
Stock and Other Ownership Interests: Novo Nordisk
Thomas E. Rohan
Stock and Other Ownership Interests: Health Outlook
Consulting or Advisory Role: Health Outlook
Patents, Royalties, Other Intellectual Property: Patents
Kathryn J. Ruddy
Research Funding: Medtronic
Patents, Royalties, Other Intellectual Property: Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification
Karen Steindorf
Honoraria: Murgpark Kuppenheim Physiotraining, Audi health insurance, Adviva Medical Technics, Pierre Fabre, Takeda
Celine M. Vachon
Stock and Other Ownership Interests: Exact Sciences
Research Funding: Grail (Inst)
Patents, Royalties, Other Intellectual Property: Breast Density software
Kala Visvanathan
Honoraria: EvolveImmune Therapeutics
Research Funding: Cepheid (Inst)
Patents, Royalties, Other Intellectual Property: Licensing of patent with Cepheid (Inst)
Uncompensated Relationships: Optra Health
Anthony J. Swerdlow
Stock and Other Ownership Interests: GlaxoSmithKline
Minouk J. Schoemaker
Employment: IQVIA
No other potential conflicts of interest were reported.
DISCLAIMER
Where authors are identified as personnel of the International Agency for Research on Cancer (IARC)/WHO, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the IARC/WHO.
SUPPORT
Supported in part by Breast Cancer Now and the United Kingdom National Health Service funding to the Royal Marsden/Institute of Cancer Research. This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health (NIH). The Black Women's Health Study was supported by NIH grants (No. R01-CA058420 and U01-CA164974). The Sister Study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (project Z01-ES044005 to D.P.S.), which also partially supported the PMBCCG. The Singapore Chinese Health Study was supported by NIH grants (No. R01-CA144034 and UM1-CA182876). The coordination of EPIC is financially supported by International Agency for Research on Cancer and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre. The national cohorts are supported by Danish Cancer Society; Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale (ANR-10-COHO-0006), Institut National de la Santé et de la Recherche Médicale (INSERM), Ministry of Higher Education, Research and Innovation, France (2102918823, 2103236497, and 2103586016); German Cancer Aid (70-2488), German Cancer Research Center (DKFZ), German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Federal Ministry of Education and Research, Germany (BMBF; 01ER0809); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, Compagnia di SanPaolo and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), LK Research Funds (36.91), Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland; 40-00812-98-10040), World Cancer Research Fund (WCRF; WCRF 98A04 and WCRF 2000/30); Health Research Fund (FIS)—Instituto de Salud Carlos III, Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology—ICO (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C8221/A29017 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk; MR/M012190/1 to EPIC-Oxford; United Kingdom). B.M.L. is supported by the Victorian Cancer Agency MCRF18-005. T.E.R. is supported in part by the Breast Cancer Research Foundation (BCRF-22-140).
H.B.N., D.P.S., A.J.S., and M.J.S. contributed equally to this work as senior authors.
DATA SHARING STATEMENT
The data that support the findings of this study are not publicly available because of privacy or ethical restrictions. Study data may be shared upon reasonable request to senior authors.
AUTHOR CONTRIBUTIONS
Conception and design: Iain R. Timmins, Michael E. Jones, A. Heather Eliassen, Xiao-Ou Shu, Elisabete Weiderpass, Walter C. Willett, Alicja Wolk, Dale P. Sandler, Anthony J. Swerdlow, Minouk J. Schoemaker
Financial support: Dale P. Sandler
Administrative support: Hazel B. Nichols
Provision of study materials or patients: Michael E. Jones, Kimberly A. Bertrand, Yu Chen, Jessica Clague DeHart, Laure Dossus, A. Heather Eliassen, Richard S. Houlston, Cari M. Kitahara, Woon-Puay Koh, Martha S. Linet, Brigid M. Lynch, Anne M. May, Roger L. Milne, Julie R. Palmer, Thomas E. Rohan, Maria-Jose Sánchez, Karen Steindorf, Celine M. Vachon, Lars J. Vatten, Walter C. Willett, Alicja Wolk, Hazel B. Nichols, Dale P. Sandler
Collection and assembly of data: Iain R. Timmins, Michael E. Jones, Laura Baglietto, Kimberly A. Bertrand, Kristen D. Brantley, Yu Chen, Jessica Clague DeHart, Tess V. Clendenen, Laure Dossus, A. Heather Eliassen, Agnès Fournier, Susan E. Hankinson, Richard S. Houlston, Victoria A. Kirsh, Cari M. Kitahara, Woon-Puay Koh, Martha S. Linet, Brigid M. Lynch, Roger L. Milne, Julie R. Palmer, Fulvio Ricceri, Maria-Jose Sánchez, Karen Steindorf, Malin Sund, Celine M. Vachon, Lars J. Vatten, Kala Visvanathan, Elisabete Weiderpass, Walter C. Willett, Alicja Wolk, Jian-Min Yuan, Wei Zheng, Hazel B. Nichols, Dale P. Sandler, Anthony J. Swerdlow, Minouk J. Schoemaker
Data analysis and interpretation: Iain R. Timmins, Michael E. Jones, Dagfinn Aune, Kristen D. Brantley, A. Heather Eliassen, Olivia Fletcher, Niclas Håkansson, Susan E. Hankinson, Richard S. Houlston, Corinne E. Joshu, Cari M. Kitahara, Hannah Lui Park, Anne M. May, Roger L. Milne, Julie R. Palmer, Thomas E. Rohan, Kathryn J. Ruddy, Maria-Jose Sánchez, Karl Smith-Byrne, Karen Steindorf, Lars J. Vatten, Kala Visvanathan, Elisabete Weiderpass, Walter C. Willett, Alicja Wolk, Wei Zheng, Anthony J. Swerdlow
Manuscript writing: All authors
Final approval of manuscript: All authors
Accountable for all aspects of the work: All authors
AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
Iain R. Timmins
Employment: AstraZeneca
Corinne E. Joshu
Honoraria: National Cancer Institute, American Cancer Society
Research Funding: National Cancer Institute (Inst), American Cancer Society (Inst), Ralph Lauren Corporate Foundation (Inst), National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) (Inst)
Lene Mellemkjaer
Employment: Novo Nordisk
Stock and Other Ownership Interests: Novo Nordisk
Thomas E. Rohan
Stock and Other Ownership Interests: Health Outlook
Consulting or Advisory Role: Health Outlook
Patents, Royalties, Other Intellectual Property: Patents
Kathryn J. Ruddy
Research Funding: Medtronic
Patents, Royalties, Other Intellectual Property: Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification
Karen Steindorf
Honoraria: Murgpark Kuppenheim Physiotraining, Audi health insurance, Adviva Medical Technics, Pierre Fabre, Takeda
Celine M. Vachon
Stock and Other Ownership Interests: Exact Sciences
Research Funding: Grail (Inst)
Patents, Royalties, Other Intellectual Property: Breast Density software
Kala Visvanathan
Honoraria: EvolveImmune Therapeutics
Research Funding: Cepheid (Inst)
Patents, Royalties, Other Intellectual Property: Licensing of patent with Cepheid (Inst)
Uncompensated Relationships: Optra Health
Anthony J. Swerdlow
Stock and Other Ownership Interests: GlaxoSmithKline
Minouk J. Schoemaker
Employment: IQVIA
No other potential conflicts of interest were reported.
REFERENCES
- 1. Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: A detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015;175:959–967. doi: 10.1001/jamainternmed.2015.0533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Sofi F, Capalbo A, Cesari F, et al. Physical activity during leisure time and primary prevention of coronary heart disease: An updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15:247–257. doi: 10.1097/HJR.0b013e3282f232ac. [DOI] [PubMed] [Google Scholar]
- 3. Rezende LFM, Sá THd, Markozannes G, et al. Physical activity and cancer: An umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br J Sports Med. 2018;52:826–833. doi: 10.1136/bjsports-2017-098391. [DOI] [PubMed] [Google Scholar]
- 4. Torre LA, Islami F, Siegel RL, et al. Global cancer in women: Burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26:444–457. doi: 10.1158/1055-9965.EPI-16-0858. [DOI] [PubMed] [Google Scholar]
- 5. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 6. Sesso HD, Paffenbarger RS, Jr, Lee IM. Physical activity and breast cancer risk in the College Alumni Health Study (United States) Cancer Causes Control. 1998;9:433–439. doi: 10.1023/a:1008827903302. [DOI] [PubMed] [Google Scholar]
- 7. Thune I, Brenn T, Lund E, et al. Physical activity and the risk of breast cancer. N Engl J Med. 1997;336:1269–1275. doi: 10.1056/NEJM199705013361801. [DOI] [PubMed] [Google Scholar]
- 8. Breslow RA, Ballard-Barbash R, Munoz K, et al. Long-term recreational physical activity and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Cancer Epidemiol Biomarkers Prev. 2001;10:805–808. [PubMed] [Google Scholar]
- 9. Margolis KL, Mucci L, Braaten T, et al. Physical activity in different periods of life and the risk of breast cancer: The Norwegian-Swedish Women's Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers Prev. 2005;14:27–32. [PubMed] [Google Scholar]
- 10. Suzuki S, Kojima M, Tokudome S, et al. Effect of physical activity on breast cancer risk: Findings of the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev. 2008;17:3396–3401. doi: 10.1158/1055-9965.EPI-08-0497. [DOI] [PubMed] [Google Scholar]
- 11. Howard RA, Leitzmann MF, Linet MS, et al. Physical activity and breast cancer risk among pre- and postmenopausal women in the U.S. Radiologic Technologists cohort. Cancer Causes Control. 2009;20:323–333. doi: 10.1007/s10552-008-9246-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Pronk A, Ji BT, Shu XO, et al. Physical activity and breast cancer risk in Chinese women. Br J Cancer. 2011;105:1443–1450. doi: 10.1038/bjc.2011.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Suzuki R, Iwasaki M, Yamamoto S, et al. Leisure-time physical activity and breast cancer risk defined by estrogen and progesterone receptor status—The Japan Public Health Center-based Prospective Study. Prev Med. 2011;52:227–233. doi: 10.1016/j.ypmed.2011.01.016. [DOI] [PubMed] [Google Scholar]
- 14. Steindorf K, Ritte R, Eomois PP, et al. Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition. Int J Cancer. 2013;132:1667–1678. doi: 10.1002/ijc.27778. [DOI] [PubMed] [Google Scholar]
- 15. Rosenberg L, Palmer JR, Bethea TN, et al. A prospective study of physical activity and breast cancer incidence in African-American women. Cancer Epidemiol Biomarkers Prev. 2014;23:2522–2531. doi: 10.1158/1055-9965.EPI-14-0448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Catsburg C, Kirsh VA, Soskolne CL, et al. Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort. Breast Cancer Res Treat. 2014;145:545–552. doi: 10.1007/s10549-014-2973-z. [DOI] [PubMed] [Google Scholar]
- 17. Wu Y, Zhang D, Kang S. Physical activity and risk of breast cancer: A meta-analysis of prospective studies. Breast Cancer Res Treat. 2013;137:869–882. doi: 10.1007/s10549-012-2396-7. [DOI] [PubMed] [Google Scholar]
- 18. Pizot C, Boniol M, Mullie P, et al. Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies. Eur J Cancer. 2016;52:138–154. doi: 10.1016/j.ejca.2015.10.063. [DOI] [PubMed] [Google Scholar]
- 19. Neilson HK, Farris MS, Stone CR, et al. Moderate-vigorous recreational physical activity and breast cancer risk, stratified by menopause status: A systematic review and meta-analysis. Menopause. 2017;24:322–344. doi: 10.1097/GME.0000000000000745. [DOI] [PubMed] [Google Scholar]
- 20. Neil-Sztramko SE, Boyle T, Milosevic E, et al. Does obesity modify the relationship between physical activity and breast cancer risk? Breast Cancer Res Treat. 2017;166:367–381. doi: 10.1007/s10549-017-4449-4. [DOI] [PubMed] [Google Scholar]
- 21. Hardefeldt PJ, Penninkilampi R, Edirimanne S, et al. Physical activity and weight loss reduce the risk of breast cancer: A meta-analysis of 139 prospective and retrospective studies. Clin Breast Cancer. 2018;18:e601–e612. doi: 10.1016/j.clbc.2017.10.010. [DOI] [PubMed] [Google Scholar]
- 22. Chan DSM, Abar L, Cariolou M, et al. World Cancer Research Fund International: Continuous Update Project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk. Cancer Causes Control. 2019;30:1183–1200. doi: 10.1007/s10552-019-01223-w. [DOI] [PubMed] [Google Scholar]
- 23. Ma H, Bernstein L, Pike MC, et al. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: A meta-analysis of epidemiological studies. Breast Cancer Res. 2006;8:R43. doi: 10.1186/bcr1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Gong Z, Hong CC, Bandera EV, et al. Vigorous physical activity and risk of breast cancer in the African American breast cancer epidemiology and risk consortium. Breast Cancer Res Treat. 2016;159:347–356. doi: 10.1007/s10549-016-3936-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Nichols HB, Schoemaker MJ, Wright LB, et al. The premenopausal breast cancer collaboration: A pooling project of studies participating in the national cancer Institute cohort consortium. Cancer Epidemiol Biomarkers Prev. 2017;26:1360–1369. doi: 10.1158/1055-9965.EPI-17-0246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA. 2018;320:2020–2028. doi: 10.1001/jama.2018.14854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: A second update of codes and MET values. Med Sci Sports Exerc. 2011;43:1575–1581. doi: 10.1249/MSS.0b013e31821ece12. [DOI] [PubMed] [Google Scholar]
- 28. Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women's Health Study: A follow-up study for causes and preventions of illness. J Am Med Womens Assoc (1972) 1995;50:56–58. [PubMed] [Google Scholar]
- 29. Olson JE, Sellers TA, Scott CG, et al. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort. Breast Cancer Res. 2012;14:R147. doi: 10.1186/bcr3357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Moore SC, Lee IM, Weiderpass E, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 2016;176:816–825. doi: 10.1001/jamainternmed.2016.1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206–2223. doi: 10.1093/annonc/mdt303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Nichols HB, Schoemaker MJ, Cai J, et al. Breast cancer risk after recent childbirth: A pooled analysis of 15 prospective studies. Ann Intern Med. 2019;170:22–30. doi: 10.7326/M18-1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Schoemaker MJ, Nichols HB, Wright LB, et al. Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women. Int J Cancer. 2020;147:1306–1314. doi: 10.1002/ijc.32892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Premenopausal Breast Cancer Collaborative Group. Schoemaker MJ, Nichols HB, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol. 2018;4:e181771. doi: 10.1001/jamaoncol.2018.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Barlow WE, Ichikawa L, Rosner D, et al. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52:1165–1172. doi: 10.1016/s0895-4356(99)00102-x. [DOI] [PubMed] [Google Scholar]
- 37. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524–532. [PubMed] [Google Scholar]
- 38. Buse A. The likelihood ratio, Wald, and Lagrange multiplier tests: An expository note. Am Stat. 1982;36:153–157. [Google Scholar]
- 39. Silvera SA, Jain M, Howe GR, et al. Energy balance and breast cancer risk: A prospective cohort study. Breast Cancer Res Treat. 2006;97:97–106. doi: 10.1007/s10549-005-9098-3. [DOI] [PubMed] [Google Scholar]
- 40.Mallinson RJ, Gibbs JC, De Souza MJ. Impact of physical activity and exercise on female reproductive potential. In: Vaamonde D, du Plessis SS, Agarwal A, editors. Exercise and Human Reproduction: Induced Fertility Disorders and Possible Therapies. New York, NY: Springer; 2016. pp. 167–185. [Google Scholar]
- 41. Loucks AB. Effects of exercise training on the menstrual cycle: Existence and mechanisms. Med Sci Sports Exerc. 1990;22:275–280. [PubMed] [Google Scholar]
- 42. Warren MP, Perlroth NE. The effects of intense exercise on the female reproductive system. J Endocrinol. 2001;170:3–11. doi: 10.1677/joe.0.1700003. [DOI] [PubMed] [Google Scholar]
- 43. De Souza MJ, Toombs RJ, Scheid JL, et al. High prevalence of subtle and severe menstrual disturbances in exercising women: Confirmation using daily hormone measures. Hum Reprod. 2010;25:491–503. doi: 10.1093/humrep/dep411. [DOI] [PubMed] [Google Scholar]
- 44. Dixon-Suen SC, Lewis SJ, Martin RM, et al. Physical activity, sedentary time and breast cancer risk: A Mendelian randomisation study. Br J Sports Med. 2022;56:1157–1170. doi: 10.1136/bjsports-2021-105132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.2018 Physical Activity Guidelines Advisory Committee . 2018 Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC: U.S. Department of Health and Human Services; 2018. [Google Scholar]
- 46. McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer. 2008;8:205–211. doi: 10.1038/nrc2325. [DOI] [PubMed] [Google Scholar]
- 47. Lynch BM, Milne RL, English DR, et al. Linking physical activity to breast cancer: Text mining results and a protocol for systematically reviewing three potential mechanistic pathways. Cancer Epidemiol Biomarkers Prev. 2022;31:11–15. doi: 10.1158/1055-9965.EPI-21-0435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Endogenous Hormones and Breast Cancer Collaborative Group. Key TJ, Appleby PN, et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: Reanalysis of 13 studies. Br J Cancer. 2011;105:709–722. doi: 10.1038/bjc.2011.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Swain CTV, Drummond AE, Boing L, et al. Linking physical activity to breast cancer via sex hormones, part 1: The effect of physical activity on sex steroid hormones. Cancer Epidemiol Biomarkers Prev. 2022;31:16–27. doi: 10.1158/1055-9965.EPI-21-0437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Drummond AE, Swain CTV, Brown KA, et al. Linking physical activity to breast cancer via sex steroid hormones, part 2: The effect of sex steroid hormones on breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2022;31:28–37. doi: 10.1158/1055-9965.EPI-21-0438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Swain CTV, Drummond AE, Milne RL, et al. Linking physical activity to breast cancer risk via insulin/insulin-like growth factor signaling system, part 1: The effect of physical activity on the insulin/insulin-like growth factor signaling system. Cancer Epidemiol Biomarkers Prev. 2022;31:2106–2115. doi: 10.1158/1055-9965.EPI-22-0504. [DOI] [PubMed] [Google Scholar]
- 52. Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: New mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15:484–498. doi: 10.1038/nrc3967. [DOI] [PubMed] [Google Scholar]
- 53. Neilson HK, Friedenreich CM, Brockton NT, et al. Physical activity and postmenopausal breast cancer: Proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev. 2009;18:11–27. doi: 10.1158/1055-9965.EPI-08-0756. [DOI] [PubMed] [Google Scholar]
- 54. Lou MWC, Drummond AE, Swain CTV, et al. Linking physical activity to breast cancer via inflammation, part 2: The effect of inflammation on breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2023;32:597–605. doi: 10.1158/1055-9965.EPI-22-0929. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are not publicly available because of privacy or ethical restrictions. Study data may be shared upon reasonable request to senior authors.
